|
Discussion of benefit and cost of therapies for rare disorders in Switzerland
|
Press |
|
Pompe sufferer has bid rejected
|
Press |
|
Sick dad's hopes crushed as $500,000 drug left out of Australia's Lifesaving Drugs Program
|
Press |
|
Court rejects reimbursement for adult Pompe patient in Switzerland
|
Press |
|
Survivor joins fight for vital drug
|
Press |
|
BioMarin Receives Orphan Drug Designation for Pompe Disease from the FDA
|
BioMarin |
|
Statement from IPA concerning Lumizyme Approval
|
IPA |
|
Genzyme Pompe Program Update - FDA Approves Lumizyme
|
Genzyme |
|
Pompe Program Update
|
Genzyme |
|
Extraordinary Measures Press Release
|
IPA |
